Disease State: Stroke Prevention in Atrial Fibrillation (SPAF)

Educational Objectives

1. Highlight healthcare provider’s challenges with managing thomboembolic disease and assist them in identifying and breaking down barriers to evidence based care.  
   
2. Improve healthcare provider’s awareness and implementation of clinical guidelines for VTE prevention and atrial fibrillation.
   
3. Increase the knowledge of pharmacological therapy to prevent thomboembolic events in both surgical and medical patients at risk.
4. Increase the knowledge of healthcare providers about the role of thrombin in the coagulation cascade.
   
5. Increase the healthcare provider knowledge of available and emerging therapeutic interventions that may prevent thromboembolic events. 
6. Increase knowledge of the scientific evidence base that describes the clinical implications of agents affecting coagulation function.

 

 

 

 

 

© 2009 Boehringer Ingelheim Corporation or an affiliated company. All rights reserved. Use of this site is subject to the terms and conditions set out in the Agreement to use the Boehringer Ingelheim Corporation and its U.S. affiliates' web sites. All content intended for U.S. residents only. Terms of Use and Privacy Policy.